Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from parental and SLX4IP-depleted D2.OR cells

ABSTRACT: Loss of SLX4IP elicits the metastatic outgrowth of nonmetastatic breast cancer cells by activating Wnt signaling to induce telomere maintenance mechanism switching We sought to assess genome-wide transcriptomic profiles governed by loss of SLX4IP expression in latent D2.OR breast cancer cells

ORGANISM(S): Mus musculus

PROVIDER: GSE125702 | GEO | 2019/01/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Expression data from D2.OR Derivatives

Project description:BORG elicits the metastatic outgrowth of nonmetastatic breast cancer cells by promoting the localization and transcriptional repressive activity of TRIM28, which binds BORG and induces substantial alterations in carcinoma in the proliferation and survival We sought to assess genome-wide transcriptomic profiles governed by BORG in a TRIM28-dependent and -independent manner in latent D2.OR breast cancer cells

2017-08-30 | GSE99234 | GEO

Expression data from parental and SLX4IP-depleted D2.OR cells

Project description:Expression data from parental and SLX4IP-depleted D2.OR cells

| PRJNA517271 | ENA

Pseudoalteromonas tunicata D2 strain:D2

Project description:Pseudoalteromonas tunicata D2 strain:D2 Genome sequencing

| PRJNA196226 | ENA

Arthrobacter sp. D2 strain:D2

Project description:Arthrobacter sp. D2 strain:D2 Genome sequencing and assembly

| PRJNA314012 | ENA

BORG-dependent alterations in the transcriptome of D2.OR cells

Project description:The ubiquitous nature of lncRNAs to comprehensively alter cellular transcriptional networks led us to hypothesize that BORG is capable of compelling metastasic, chemoresistant, and pro-survival activities in triple-negative breast cancers by inducing global transcriptomic reprogramming. As such, we performed RNA-seq to garner mechanistic insights into BORG-dependent pathways within D2.OR cells. Accordingly, transcriptional profiles associated with aggressive breast cancers and adaptive survival programs were amongst the top enriched pathways in BORG-expressing D2.OR cells. Most notably, BORG enriched for gene signatures that were critical for the development of chemoresistance towards doxorubicin, as well as a core set of genes upregulated in response to hypoxia, radiotherapy, and serum-deprivation.

2019-03-27 | GSE116656 | GEO

Kocuria rhizophila strain:D2 | isolate:D2

Project description:Kocuria rhizophila strain:D2 | isolate:D2 Genome sequencing and assembly

| PRJNA427247 | ENA

Gene expression profile of D2.OR-EGFP and D2.A1-EGFP cells in vitro and in vivo

Project description:We analysed gene expression profiles of D2.OR-EGFP and D2.A1-EGFP cells isolated from lungs and under standard in vitro conditions

2020-02-24 | GSE120628 | GEO

Transcription profiling of mouse lung from C57BL6 and DBA2 parental strains and D2.B6-Chr7 and D2.B6-Chr19 congenic mice following aerosol infection with Mycobacterium tuberculosis for 30 and 70 days

Project description:To gain insight into the host cell types, cellular and molecular pathways possibly involved in the differential permissiveness to pulmonary replication of M. tuberculosis, we carried out transcript profiling studies on M. tuberculosis-infected lungs from congenic and parental strains. We were particularly interested in two groups of transcripts. The first group consists of transcripts which expression in the lung is regulated in response to M. tuberculosis infection (global response to infection), and that is obtained by comparing transcripts profiles of infected vs. uninfected lungs. The second group of transcripts is associated with increased resistance to M. tuberculosis infection of B6 and D2.B6-Chr7 mice. That list consists in the overlap between the lists commonly expressed in response to infection between resistant B6 and D2.B6-Chr7 but that show a significant difference in modulation when compared to infected susceptible D2.<br><br> In these experiments, B6, D2 as well as the D2.B6-Chr19, and D2.B6-Chr7 congenic lines were infected with M. tuberculosis and lungs were harvested at day 30 and day 70, and RNA was prepared. Three independent RNA samples from each group were converted to labeled cDNAs and hybridized to Affymetrix oligonucleotides arrays (Mouse Genome 430 2.0 array). Hybridization results were analyzed with the Genesifter analysis program to characterize changes in gene expression.

2009-02-20 | E-MEXP-1942 | biostudies-arrayexpress

RNA-sequencing of D2A1 and D2.OR cell lines in both 2D and 3D cultures

Project description:Reactivation of dormant cancer cells can lead to cancer relapse, metastasis and patient death. Dormancy is a non-proliferative state and is linked to late relapse and death. No targeted therapy is currently available to eliminate dormant cells, highlighting the need for a deeper understanding and reliable models. Here, we thoroughly characterize the dormant D2.OR and proliferative D2A1 breast cancer cell line models in vivo and in vitro, and assess if there is overlap between a dormant and a senescent phenotype. We show that D2.OR but not D2A1 cells become dormant in the liver of an immunocompetent model. In vitro, we show that D2.OR cells are polyploid ER+/Her2+ cells, and in response to a 3D environment are growth arrested in G1, of which a subpopulation resides in a 4NG1 state. The dormancy state is reversible, and not associated with a senescence phenotype. This will aid future research on breast cancer dormancy.

2021-09-19 | GSE172882 | GEO

Proteomic analysis revealed the potential role of MAGE-D2 in therapeutic targeting of triple-negative breast cancer

Project description:Triple negative breast cancer (TNBC) is one of the most aggressive molecular subtypes in breast cancer. Due to the lack of effective therapeutic targets, the clinical outcomes for TNBC patients remain poor. Here, we performed an integrated proteomic analysis including bioinformatic analysis of proteome database, label-free proteomics, and immunoprecipitation coupled with mass spectrometry (IP-MS) to explore potential therapeutic targets for TNBC. Bioinformatic analysis showed that MAGE-D2 was overexpressed in TNBC. In vivo and in vitro experiments indicated that MAGE-D2 overexpression could promote TNBC proliferation and metastasis. In addition, label-free proteomics revealed that MAGE-D2 played a cancer-promoting role by activating PI3K/AKT pathway. Moreover, the results of IP-MS and cross-linking/xIP-MS demonstrated that MAGE-D2 could interact with Hsp70 and prevent Hsp70 degradation. Therefore, MAGE-D2 could be a potential therapeutic target for TNBC, and inhibiting MAGE-D2 may have important therapeutic relevance.

2023-03-07 | PXD040645 | iProX

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data